[1]
2026. CLINICAL OUTCOMES OF NEOADJUVANT CONCURRENT CHEMORADIOTHERAPY USING VOLUMETRIC MODULATED ARC THERAPY IN PATIENTS WITH STAGE II-IVA MIDDLE AND LOWER THORACIC ESOPHAGEAL CANCER. Vietnam Journal of Community Medicine. 67, Số CĐ12- Bệnh viện Ung bướu Nghệ An (Aug. 2026). DOI:https://doi.org/10.52163/yhc.v67iCD12.6130.